IL-33 has been proposed to participate in the development of lung fibrosis in bleomycin-induced mouse models [64], and it will be of interest to further explore whether IL-33 is involved in other models of extracellular matrix deposition in the lung [23] or different tissues. This evidence concerns the gene IL33 and pulmonary fibrosis.